Prodromal and Early Parkinsonism Alpha-Synuclein Study
Single-center, cross-sectional biospecimen study of alpha-synuclein seed amplification assays in prodromal or early undifferentiated parkinsonism.
Product Design & Consulting | NYU Langone Health
NYU Langone Occupational and Industrial Orthopedic Center specialists provide biomechanical and ergonomic usability evaluations for businesses.
Professional Billing Compliance | NYU Langone Health
We support physicians, other providers, and administrators to ensure accurate billing, coding, and documentation for professional services.
Programs & Services at NYU Langone Orthopedic Hospital | NYU Langone Health
NYU Langone Orthopedic Hospital offers programs and services for orthopedic, rheumatologic, musculoskeletal, and neuromuscular disorders.
Programs for Those with Memory Loss & Their Caregivers | NYU Langone Health
NYU Langone’s Alzheimer’s Disease and Related Dementias Family Support Program has programs for people with memory loss and their caregivers.
Programs, Workshops & Classes for Women with Disabilities | NYU Langone Health
NYU Langone’s Initiative for Women with Disabilities at the Elly and Steve Hammerman Health and Wellness Center offers programs and classes.
Promoting wellness in individuals with traumatic brain injury: A randomized trial assessing the effectiveness of the mindfulness exercise nutrition to optimize resilience (MENTOR) program
This randomized trial aims to determine the effectiveness of an online wellness intervention program focused on mindfulness, physical activity, and nutrition in individuals with traumatic brain injury (TBI). This study will provide insights into the impact of the intervention’s components in helping emotional, physical, and nutritional outcomes post-injury in the context of social determinants of health. Participants will be randomized at enrollment into two groups: immediate treatment (IT) and delayed treatment (DT) group. All study participants will receive the behavioral intervention that consists of an eight-week cycle of 40 hours (up to five hours per week) of group-based instruction and discussion. After the intervention, the IT group will complete an eight-week retention period. Individuals in the DT will begin in an eight-week waitlist period, followed by the intervention and retention periods. Study assessments will be completed after each study period for both groups.
Prophylaxis with Direct-acting Antivirals for Kidney Transplantation from Hepatitis C Virus-Infected Donors to Uninfected Recipients: a Randomized Controlled Trial
The purpose of this research study is to learn about the best approach to treat Hepatitis C Virus (HCV) in kidney transplant recipients.
Prospective Cohort Registry of Patients with Inflammatory Bowel Disease and Overlap Spondyloarthritis
The purpose of this research study is to use two questionnaires to identify patients who have both inflammatory bowel disease and spondyloarthritis and to then track their joint disease activity during their standard care of management.
Prospective Database of Clinical Outcomes Following Cryotherapy for ablation of clinically localized prostate cancer
Primary Objective: To record the treatment results and impact on clinical parameters following of Cryotherapy for ablation of clinically localized prostate cancer. Primary outcome variables of interest include PSA-progression free survival, histologic evaluation of treatment efficacy and imaging surveillance of treatment effects.Secondary Objectives: To determine the long-term urinary and sexual side effects following Cryo prostate ablation treatment.Background and RationaleMany reports of clinical outcomes following treatment of localized prostate cancer suffer from lack of prospective long-term data using objective and validated outcome instruments. The purpose of this database is to prospectively collect data to assessing oncologic outcomes and urinary/sexual function after Cryoablation of prostate cancer with the intent to guide further research and improve patient care. Only patients of Herbert Lepor, M.D. and James Wysock, M.D. will be entered into this database.